RAPT Therapeutics, Inc.
RAPT
$0.9129
-$0.0082-0.89%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -53.25M | -18.43M | -27.66M | -30.52M | -30.88M |
| Total Depreciation and Amortization | 287.00K | 297.00K | 305.00K | 314.00K | 323.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.64M | 4.60M | 5.22M | 5.00M | 3.79M |
| Change in Net Operating Assets | 37.88M | -4.08M | -6.02M | -1.88M | -990.00K |
| Cash from Operations | -10.44M | -17.62M | -28.15M | -27.08M | -27.75M |
| Capital Expenditure | -1.00K | -17.00K | 1.00K | -105.00K | -67.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -842.00K | 18.46M | 19.21M | 15.99M | 20.71M |
| Cash from Investing | -843.00K | 18.45M | 19.21M | 15.89M | 20.64M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 143.12M | 0.00 | 701.00K | 9.04M | 458.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 143.12M | 0.00 | 701.00K | 9.04M | 458.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 131.84M | 823.00K | -8.24M | -2.16M | -6.66M |